Exhibit 99.2

MEDCATH CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(Unaudited)

	Three Months Ended March 31,						Six Months Ended March 31,
	2009			2008			2009			2008
Net revenue	$	158,867		$	154,200		$	311,970		$	300,895
Operating expenses:
Personnel expense		52,127			49,156			102,783			99,540
Medical supplies expense		43,811			41,656			86,462			80,398
Bad debt expense		10,618			10,332			22,011			21,617
Other operating expenses		32,344			30,424			64,580			59,442
Pre-opening expenses		380			245			587			493
Depreciation		7,565			7,689			15,400			15,030
Amortization		210			135			359			262
Loss on disposal of property, equipment and other assets		91			138			164			166
Total operating expenses		147,146			139,775			292,346			276,948
Income from operations		11,721			14,425			19,624			23,947
Other income (expenses):
Interest expense		(1,338	)		(3,864	)		(4,194	)		(7,796	)
Gain (loss) on early extinguishment of debt		259			—			(6,702	)		—
Interest and other income, net		73			485			173			1,646
Equity in net earnings of unconsolidated affiliates		2,714			2,181			4,779			4,206
Total other expenses, net		1,708			(1,198	)		(5,944	)		(1,944	)
Income from continuing operations before minority interest and income taxes		13,429			13,227			13,680			22,003
Minority interest share of earnings of consolidated subsidiaries		(4,639	)		(4,642	)		(7,415	)		(8,779	)
Income from continuing operations before income taxes		8,790			8,585			6,265			13,224
Income tax expense		3,372			3,099			2,463			5,448
Income from continuing operations		5,418			5,486			3,802			7,776
Income from discontinued operations, net of taxes		164			199			4,026			973
Net income	$	5,582		$	5,685		$	7,828		$	8,749
Earnings per share, basic
Continuing operations	$	0.28		$	0.28		$	0.19		$	0.38
Discontinued operations		0.01			0.01			0.21			0.05
Earnings per share, basic	$	0.28		$	0.29		$	0.40		$	0.43
Earnings per share, diluted
Continuing operations	$	0.28		$	0.28		$	0.19		$	0.37
Discontinued operations		0.01			0.01			0.21			0.05
Earnings per share, diluted	$	0.28		$	0.29		$	0.40		$	0.42
Weighted average number of shares, basic		19,664			19,841			19,631			20,438
Dilutive effect of stock options and restricted stock		26			121			—			202
Weighted average number of shares, diluted		19,690			19,962			19,631			20,640

MEDCATH CORPORATION
CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)

	March 31,			September 30,
	2009			2008
	(Unaudited)
Current assets:
Cash and cash equivalents	$	42,883		$	93,836
Restricted cash		3,166			3,154
Accounts receivable, net		89,638			83,875
Income tax receivable, net		1,275			3,091
Medical supplies		17,661			15,479
Deferred income tax assets		8,643			9,769
Prepaid expenses and other current assets		10,545			9,796
Current assets of discontinued operations		12,531			20,776
Total current assets		186,342			239,776
Property and equipment, net		357,285			323,729
Investments in affiliates		12,676			15,285
Goodwill		60,174			60,174
Other intangible assets, net		6,266			6,063
Other assets		7,767			8,378
Long-term assets of discontinued operations		—			51
Total assets	$	630,510		$	653,456
Current liabilities:
Accounts payable	$	41,513		$	41,642
Accrued compensation and benefits		19,596			16,872
Other accrued liabilities		22,265			24,054
Current portion of long-term debt and obligations under capital leases		11,991			31,920
Current liabilities of discontinued operations		9,465			10,184
Total current liabilities		104,830			124,672
Long-term debt		112,038			115,628
Obligations under capital leases		1,845			2,087
Deferred income tax liabilities		12,170			12,352
Other long-term obligations		3,006			4,454
Total liabilities		233,889			259,193
Minority interest in equity of consolidated subsidiaries		18,929			24,667
Stockholders’ equity:
Preferred stock, $0.01 par value, 10,000,000 shares authorized; none issued		—			—
Common stock, $0.01 par value, 50,000,000 shares authorized; 21,684,780 issued and 19,730,419 outstanding at March 31, 2009; 21,553,054 issued and 19,598,693 outstanding at September 30, 2008		216			216
Paid-in capital		456,035			455,494
Accumulated deficit		(33,310	)		(41,138	)
Accumulated other comprehensive loss		(452	)		(179	)
Treasury stock, at cost;
1,954,361 shares at March 31, 2009
1,954,361 shares at September 30, 2008		(44,797	)		(44,797	)
Total stockholders’ equity		377,692			369,596
Total liabilities and stockholders’ equity	$	630,510		$	653,456

MEDCATH CORPORATION
SELECTED OPERATING DATA
(In thousands, except per share data and selected operating data)
(Unaudited)

	Three Months Ended March 31,							Six Months Ended March 31,
	2009		2008		% Change			2009		2008		% Change
Statement of Operations Data:
Net revenue	$	158,867	$	154,200		3.0	%	$	311,970	$	300,895		3.7	%
Adjusted EBITDA (1)	$	20,806	$	22,845		(8.9	)%	$	37,971	$	43,820		(13.3	)%
Income from operations	$	11,721	$	14,425		(18.7	)%	$	19,624	$	23,947		(18.1	)%
Income from continuing operations	$	5,418	$	5,486		(1.2	)%	$	3,802	$	7,776		(51.1	)%
Earnings per share from continuing operations, basic	$	0.28	$	0.28		—		$	0.19	$	0.38		(50.0	)%
Earnings per share from continuing operations, diluted	$	0.28	$	0.28		—		$	0.19	$	0.37		(48.6	)%

(1) See Supplemental Financial Disclosure—Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures.

	Three Months Ended March 31,									Six Months Ended March 31,
	2009			2008			% Change			2009			2008			% Change
Selected Operating Data (a):
Number of hospitals		7			7						7			7
Licensed beds ( c )		509			449						509			449
Staffed and available beds ( d )		462			433						462			433
Admissions ( e )		7,052			7,855			(10.2	)%		13,814			15,005			(7.9	)%
Adjusted admissions ( f )		10,556			10,817			(2.4	)%		20,436			20,645			(1.0	)%
Patient days ( g )		28,075			29,039			(3.3	)%		53,208			54,499			(2.4	)%
Adjusted patient days ( h )		42,117			40,247			4.6	%		79,028			75,381			4.8	%
Average length of stay (days) ( i )		3.98			3.70			7.6	%		3.85			3.63			6.1	%
Occupancy ( j )		67.5	%		73.7	%					63.3	%		68.8	%
Inpatient catheterization procedures ( k )		3,451			4,225			(18.3	)%		7,006			8,274			(15.3	)%
Inpatient surgical procedures ( l )		2,087			2,120			(1.6	)%		4,087			4,069			0.4	%
Hospital net revenue	$	150,567		$	144,778			4.0	%	$	294,792		$	281,929			4.6	%
Combined Operating Data (b):
Number of hospitals		9			9						9			9
Licensed beds ( c )		676			616						676			616
Staffed and available beds ( d )		625			596						625			596
Admissions ( e )		10,000			10,539			(5.1	)%		19,744			20,308			(2.8	)%
Adjusted admissions ( f )		15,255			15,164			0.6	%		29,880			29,326			1.9	%
Patient days ( g )		37,341			37,812			(1.2	)%		71,479			71,537			(0.1	)%
Adjusted patient days ( h )		56,658			54,130			4.7	%		107,679			102,599			5.0	%
Average length of stay (days) ( i )		3.73			3.59			3.9	%		3.62			3.52			2.8	%
Occupancy ( j )		66.4	%		69.7	%					62.8	%		65.6	%
Inpatient catheterization procedures ( k )		4,259			5,025			(15.2	)%		8,647			9,801			(11.8	)%
Inpatient surgical procedures ( l )		2,720			2,754			(1.2	)%		5,332			5,442			(2.0	)%
Hospital net revenue	$	191,468		$	186,045			2.9	%	$	376,491		$	362,751			3.8	%

(a)	Selected operating data includes consolidated hospitals in operation as of the end of the period reported in continuing operations but does not include hospitals which are accounted for using the equity method or as discontinued operations in our consolidated financial statements.
(b)	Combined operating data includes hospitals in operation as of the end of the period reported in continuing operations including hospitals which are accounted for using the equity method in our consolidated financial statements.
(c)	Licensed beds represent the number of beds for which the appropriate state agency licenses a facility regardless of whether the beds are actually available for patient use.
(d)	Staffed and available beds represent the number of beds that are readily available for patient use at the end of the period.
(e)	Admissions represent the number of patients admitted for inpatient treatment.
(f)	Adjusted admissions is a general measure of combined inpatient and outpatient volume. We computed adjusted admissions by dividing gross patient revenue by gross inpatient revenue and then multiplying the quotient by admissions.
(g)	Patient days represent the total number of days of care provided to inpatients.
(h)	Adjusted patient days is a general measure of combined inpatient and outpatient volume. We computed adjusted patient days by dividing gross patient revenue by gross inpatient revenue and then multiplying the quotient by patient days.
(i)	Average length of stay (days) represents the average number of days inpatients stay in our hospitals.
(j)	We computed occupancy by dividing patient days by the number of days in the period and then dividing the quotient by the number of staffed and available beds.
(k)	Inpatients with a catheterization procedure represent the number of inpatients with a procedure performed in one of the hospitals’ catheterization labs during the period.
(l)	Inpatient surgical procedures represent the number of surgical procedures performed on inpatients during the period.

MEDCATH CORPORATION
SUPPLEMENTAL FINANCIAL DISCLOSURE — RECONCILIATION OF GAAP FINANCIAL MEASURES
TO NON-GAAP FINANCIAL MEASURES
(Unaudited)

The following table reconciles Adjusted EBITDA with MedCath’s income from continuing operations as derived directly from
MedCath’s consolidated financial statements for the three and six months ended March 31, 2009 and 2008.

	Three Months Ended March 31,						Six Months Ended March 31,
	2009			2008			2009			2008
	(in thousands)						(in thousands)
Income from continuing operations	$	5,418		$	5,486		$	3,802		$	7,776
Add:
Income tax expense		3,372			3,099			2,463			5,448
Minority interest share of earnings of consolidated subsidiaries		4,639			4,642			7,415			8,779
Equity in net earnings of unconsolidated affiliates		(2,714	)		(2,181	)		(4,779	)		(4,206	)
Interest and other income, net		(73	)		(485	)		(173	)		(1,646	)
(Gain) loss on early extinguishment of debt		(259	)		—			6,702			—
Interest expense		1,338			3,864			4,194			7,796
Loss on disposal of property, equipment and other assets		91			138			164			166
Amortization		210			135			359			262
Depreciation		7,565			7,689			15,400			15,030
Pre-opening expenses		380			245			587			493
Share-based compensation expense		839			213			1,837			3,922
Adjusted EBITDA	$	20,806		$	22,845		$	37,971		$	43,820